Back to search results

Precision Genomics Medicine Biobank Study

This study, called the Precision Genomics Medicine Biobank, is collecting biological samples (like tissue or fluid), health information, and lab results from people seen at Intermountain Healthcare. The goal is to create a large collection of data to help improve healthcare and predict health outcomes in the future. You can join if you are an adult (18 or older) and are either healthy or have any health condition, as long as you are seen at an Intermountain Healthcare facility. This is an observational study, meaning there are no new treatments or procedures involved. The study aims to collect samples from 100,000 people. The current status of the study is unclear.

Study design
This is an observational study with no specific phase, aiming to enroll 100,000 participants. It is an open, long-term study that is not randomized.
What's involved
Participants will have visits for informed consent and collection of biological samples, and possibly a hand dynamometer test. Sample collection may also happen during routine standard of care visits.
Compensation
Not stated in the trial record.
Follow-up
The primary endpoints for biobanking are measured at Day 0, indicating no long-term follow-up for these specific measures.

AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.

NCT04187729

Precision Genomics Medicine Biobank

Recruiting
Not specifiedAges 18+Observational
Intermountain Health Care, Inc.
~100,000 participants
Updated 2022-04-20 on ClinicalTrials.gov

At a glance

Recruiting sites
1 of 1 listed site is recruiting right now
RecruitingSuspended, closed, or not yet open
What they're measuring
Biobank for precision genomics
Measured over Day 0
+2 more outcomes measured

Conditions

Any Disease Condition and Reportedly-healthy Subjects

Explore related trials

Any Disease ConditionHealthy

Where it's being run

1 sites across 1 states
Utah1

Who to contact

Tyler Barker, PhD
[email protected]
801-507-3653
Email the study team

Opens a ready-to-send draft in your own email app — review before sending.

Do you actually qualify for this trial?

Add a private profile and we'll compare every criterion below against your situation — and tell you which ones are met, uncertain, or excluding.

Check eligibility for this trial ~2 min · HIPAA-protected · delete anytime
Eligibility criteria

Inclusion

Male and female adults (≥ 18 years of age)
Diagnosed with any healthcare-related condition(s)
Subject presenting to an Intermountain Healthcare facility
Male and female adults (≥ 18 years of age)
Reportedly healthy (i.e., non-diseased)
Subject presenting to an Intermountain Healthcare facility

Exclusion

Inability or refusal of the patient and/or the patient's legally-acceptable representative to provide informed consent for any reason
Other conditions that the Principal Investigators or Co-Investigators believe may increase the risk to the subject and/or compromise the scientific integrity of the registry

What this trial measures

  • Biobank for precision genomicsDay 0

    There are no primary endpoints planned for this biobank and endpoints will be specific to future research hypotheses. Investigators anticipate examining genetic and genomic data using a variety of molecular and cellular analysis techniques and in various tissues and fluids.

  • Biobank for precision transcriptomicsDay 0

    There are no primary endpoints planned for this biobank and endpoints will be specific to future research hypotheses. Investigators anticipate examining transcriptomic data using a variety of molecular and cellular analysis techniques and in various tissues and fluids.

  • Biobank for precision proteomicsDay 0

    There are no primary endpoints planned for this biobank and endpoints will be specific to future research hypotheses. Investigators anticipate examining proteomic data using a variety of molecular and cellular analysis techniques and in various tissues and fluids.